Annual Income Tax
$245.70 M
-$274.70 M-52.79%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual income tax is currently $245.70 million, with the most recent change of -$274.70 million (-52.79%) on 31 December 2023. During the last 3 years, it has fallen by -$51.50 million (-17.33%). REGN annual income tax is now -80.35% below its all-time high of $1.25 billion, reached on 31 December 2021.REGN Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Income Tax
$152.40 M
-$43.40 M-22.17%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly income tax is currently $152.40 million, with the most recent change of -$43.40 million (-22.17%) on 30 September 2024. Over the past year, it has increased by +$49.40 million (+47.96%). REGN quarterly income tax is now -76.69% below its all-time high of $653.90 million, reached on 30 June 2021.REGN Quarterly Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Income Tax
$314.90 M
+$49.40 M+18.61%
30 September 2024
Summary:
Regeneron Pharmaceuticals TTM income tax is currently $314.90 million, with the most recent change of +$49.40 million (+18.61%) on 30 September 2024. Over the past year, it has dropped by -$70.40 million (-18.27%). REGN TTM income tax is now -74.82% below its all-time high of $1.25 billion, reached on 31 December 2021.REGN TTM Income Tax Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Income Tax Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.8% | +48.0% | -18.3% |
| 3 y3 years | -17.3% | -17.4% | -70.0% |
| 5 y5 years | +125.2% | +54.1% | +341.6% |
REGN Income Tax High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -80.3% | at low | -44.5% | +815.5% | -74.8% | +71.0% |
| 5 y | 5 years | -80.3% | +125.2% | -76.7% | +815.5% | -74.8% | +341.6% |
| alltime | all time | -80.3% | +173.2% | -76.7% | +145.4% | -74.8% | +193.8% |
Regeneron Pharmaceuticals Income Tax History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $152.40 M(-22.2%) | $314.90 M(+18.6%) |
| June 2024 | - | $195.80 M(-1019.2%) | $265.50 M(+44.1%) |
| Mar 2024 | - | -$21.30 M(+77.5%) | $184.20 M(-25.0%) |
| Dec 2023 | $245.70 M(-52.8%) | -$12.00 M(-111.7%) | $245.70 M(-36.2%) |
| Sept 2023 | - | $103.00 M(-10.0%) | $385.30 M(-19.1%) |
| June 2023 | - | $114.50 M(+184.8%) | $476.40 M(+0.7%) |
| Mar 2023 | - | $40.20 M(-68.5%) | $473.00 M(-9.1%) |
| Dec 2022 | $520.40 M(-58.4%) | $127.60 M(-34.3%) | $520.40 M(-22.0%) |
| Sept 2022 | - | $194.10 M(+74.7%) | $667.20 M(+1.5%) |
| June 2022 | - | $111.10 M(+26.8%) | $657.50 M(-45.2%) |
| Mar 2022 | - | $87.60 M(-68.1%) | $1.20 B(-4.0%) |
| Dec 2021 | $1.25 B(+320.8%) | $274.40 M(+48.8%) | $1.25 B(+18.9%) |
| Sept 2021 | - | $184.40 M(-71.8%) | $1.05 B(+2.8%) |
| June 2021 | - | $653.90 M(+374.5%) | $1.02 B(+161.7%) |
| Mar 2021 | - | $137.80 M(+82.8%) | $391.00 M(+31.6%) |
| Dec 2020 | $297.20 M(-5.1%) | $75.40 M(-51.7%) | $297.20 M(-7.0%) |
| Sept 2020 | - | $156.20 M(+623.1%) | $319.60 M(+21.8%) |
| June 2020 | - | $21.60 M(-50.9%) | $262.30 M(-3.7%) |
| Mar 2020 | - | $44.00 M(-55.0%) | $272.30 M(-13.1%) |
| Dec 2019 | $313.30 M(+187.2%) | $97.80 M(-1.1%) | $313.30 M(+339.4%) |
| Sept 2019 | - | $98.90 M(+213.0%) | $71.30 M(+424.3%) |
| June 2019 | - | $31.60 M(-62.8%) | $13.60 M(-84.3%) |
| Mar 2019 | - | $85.00 M(-158.9%) | $86.70 M(-20.5%) |
| Dec 2018 | $109.10 M(-87.6%) | -$144.20 M(-450.0%) | $109.10 M(-82.8%) |
| Sept 2018 | - | $41.20 M(-60.6%) | $634.55 M(-17.7%) |
| June 2018 | - | $104.70 M(-2.5%) | $770.64 M(-4.2%) |
| Mar 2018 | - | $107.40 M(-71.8%) | $804.04 M(-8.6%) |
| Dec 2017 | $880.00 M(+102.6%) | $381.25 M(+115.0%) | $880.00 M(+49.9%) |
| Sept 2017 | - | $177.29 M(+28.4%) | $587.17 M(+14.9%) |
| June 2017 | - | $138.11 M(-24.7%) | $510.96 M(+9.0%) |
| Mar 2017 | - | $183.36 M(+107.4%) | $468.89 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $434.30 M(-26.3%) | $88.42 M(-12.5%) | $434.30 M(+3.9%) |
| Sept 2016 | - | $101.08 M(+5.2%) | $418.18 M(-16.4%) |
| June 2016 | - | $96.04 M(-35.4%) | $499.99 M(-6.9%) |
| Mar 2016 | - | $148.77 M(+105.8%) | $537.30 M(-8.8%) |
| Dec 2015 | $589.04 M(+39.2%) | $72.30 M(-60.5%) | $589.04 M(-4.4%) |
| Sept 2015 | - | $182.89 M(+37.1%) | $616.37 M(+15.9%) |
| June 2015 | - | $133.35 M(-33.5%) | $531.93 M(+4.1%) |
| Mar 2015 | - | $200.50 M(+101.3%) | $511.03 M(+20.8%) |
| Dec 2014 | $423.11 M(+49.7%) | $99.63 M(+1.2%) | $423.11 M(+1.1%) |
| Sept 2014 | - | $98.45 M(-12.5%) | $418.47 M(+3.5%) |
| June 2014 | - | $112.45 M(-0.1%) | $404.40 M(+14.8%) |
| Mar 2014 | - | $112.58 M(+18.5%) | $352.27 M(+24.6%) |
| Dec 2013 | $282.64 M(-184.2%) | $94.99 M(+12.6%) | $282.64 M(-290.7%) |
| Sept 2013 | - | $84.38 M(+39.9%) | -$148.20 M(-36.3%) |
| June 2013 | - | $60.32 M(+40.4%) | -$232.57 M(-20.6%) |
| Mar 2013 | - | $42.96 M(-112.8%) | -$292.89 M(-12.8%) |
| Dec 2012 | -$335.85 M(>+9900.0%) | -$335.85 M(<-9900.0%) | -$335.85 M(>+9900.0%) |
| Sept 2012 | - | $0.00(0.0%) | -$615.00 K(+1060.4%) |
| June 2012 | - | $0.00(-100.0%) | -$53.00 K(-95.3%) |
| Dec 2011 | -$1.13 M(<-9900.0%) | -$615.00 K(-209.4%) | -$1.13 M(+119.0%) |
| Sept 2011 | - | $562.00 K(-165.1%) | -$517.00 K(-52.1%) |
| June 2011 | - | -$863.00 K(+299.5%) | -$1.08 M(+399.5%) |
| Mar 2011 | - | -$216.00 K(<-9900.0%) | -$216.00 K(<-9900.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2009 | -$4.12 M(-275.3%) | - | - |
| Mar 2009 | - | $0.00(-100.0%) | $2.35 M(0.0%) |
| Dec 2008 | $2.35 M(>+9900.0%) | -$728.00 K(-123.6%) | $2.35 M(-23.6%) |
| Sept 2008 | - | $3.08 M | $3.08 M |
| Dec 2007 | $0.00 | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual income tax?
- What is the all time high annual income tax for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual income tax year-on-year change?
- What is Regeneron Pharmaceuticals quarterly income tax?
- What is the all time high quarterly income tax for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly income tax year-on-year change?
- What is Regeneron Pharmaceuticals TTM income tax?
- What is the all time high TTM income tax for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM income tax year-on-year change?
What is Regeneron Pharmaceuticals annual income tax?
The current annual income tax of REGN is $245.70 M
What is the all time high annual income tax for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual income tax is $1.25 B
What is Regeneron Pharmaceuticals annual income tax year-on-year change?
Over the past year, REGN annual income tax has changed by -$274.70 M (-52.79%)
What is Regeneron Pharmaceuticals quarterly income tax?
The current quarterly income tax of REGN is $152.40 M
What is the all time high quarterly income tax for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly income tax is $653.90 M
What is Regeneron Pharmaceuticals quarterly income tax year-on-year change?
Over the past year, REGN quarterly income tax has changed by +$49.40 M (+47.96%)
What is Regeneron Pharmaceuticals TTM income tax?
The current TTM income tax of REGN is $314.90 M
What is the all time high TTM income tax for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM income tax is $1.25 B
What is Regeneron Pharmaceuticals TTM income tax year-on-year change?
Over the past year, REGN TTM income tax has changed by -$70.40 M (-18.27%)